Ensysce Biosciences Inc (ENSC) — Capital Reinvestment Ratio

Latest as of March 2020: 0.00x

Ensysce Biosciences Inc (ENSC) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($136.09 Million) in capital expenditures ($4.00). See net asset quality index of Ensysce Biosciences Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$136.09 Million
USD

Capital Expenditures

$4.00
USD

Data as of

Mar 2020
Most recent filing

Ensysce Biosciences Inc Capital Reinvestment Ratio (2019–2019)

This chart tracks Ensysce Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Check Ensysce Biosciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Ensysce Biosciences Inc (2019–2019)

Year-by-year Capital Reinvestment Ratio for Ensysce Biosciences Inc from 2019 to 2019. For live market cap and broader valuation context, see how much is Ensysce Biosciences Inc worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.00x $10.99 Million $4.00
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow